The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–257 of 257
VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer
Zhang, Y., Shen, H., Withers, H. G., Yang, N., Denson, K. E., Mussell, A. L., Truskinovsky, A. M., Fan, Q., Gelman, I. H., Frangou, C. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06227-7 · Cited by 68
Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues
Cao, L., Sun, P., Yao, M., Jia, M., & Gao, H. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.08.032 · Cited by 67
Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia
Lim, Y., Gondek, L. P., Li, L., Wang, Q., Ma, H., Chang, E., Huso, D. L., Foerster, S., Marchionni, L., McGovern, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5731 · Cited by 65
CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
Dai, M., Zhang, C., Ali, A., Hong, X., Tian, J., Lo, C., Fils-Aimé, N., Burgos, S. A., Ali, S., & Lebrun, J. J. (2016) · Scientific Reports · doi:10.1038/srep35383 · Cited by 65
Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation
Griffiths, E. A., Gore, S. D., Hooker, C., McDevitt, M. A., Karp, J. E., Smith, B. D., Mohammad, H. P., Ye, Y., Herman, J. G., & Carraway, H. E. (2010) · Leukemia & Lymphoma · doi:10.3109/10428194.2010.496505 · Cited by 63
Gamma Secretase Inhibition by BMS-906024 Enhances Efficacy of Paclitaxel in Lung Adenocarcinoma
Morgan, K. M., Fischer, B. S., Lee, F. Y., Shah, J. J., Bertino, J. R., Rosenfeld, J., Singh, A., Khiabanian, H., & Pine, S. R. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0439 · Cited by 63
Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells
Yun, J., Pannuti, A., Espinoza, I., Zhu, H., Hicks, C., Zhu, X., Caskey, M. W., Rizzo, P., D'Souza, G., Backus, K. V., et al. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.26 · Cited by 62
A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors
Menon, M. R., Elliott, R. J. R., Bowers, L., Balan, N., Rafiq, R., Costa-Cabral, S., Munkonge, F. M., Trinidade, I., Porter, R. A., Campbell, A. D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36447-4 · Cited by 60
Miles, K. M., Seshadri, M., Ciamporcero, E. S., Adelaiye-Ogala, R. M., Gillard, B. M., Sotomayor, P. C., Attwood, K. M., Shen, L., Conroy, D., Kuhnert, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112371 · Cited by 59
Díaz-Padilla, I., Hirte, H. W., Oza, A. M., Clarke, B. A., Cohen, B. L., Reedjik, M., Zhang, T., Kamel‐Reid, S., Ivy, S. P., Hotte, S. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-0001-5 · Cited by 58
Lee, C., Das, B., Lin, T. L., Grimes, C., Zhang, X., Lavezzi, T., Huang, L., COLE, J. T., Yau, L. C., & Li, L. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09123.x · Cited by 58
Kocemba‐Pilarczyk, K. A., Groen, R. W. J., van Andel, H., Kersten, M. J., Mahtouk, K., Spaargaren, M., & Pals, S. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030359 · Cited by 58
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
Aberger, F., Hutterer, E., Sternberg, C., del Burgo, P. J., & Hartmann, T. N. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0163-4 · Cited by 58
Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
Sekido, Y. (2018) · Cancers · doi:10.3390/cancers10040090 · Cited by 58
Karvonen, H., Perttilä, R., Niininen, W., Hautanen, V., Barker, H. R., Murumägi, A., Heckman, C. A., & Ungureanu, D. (2019) · Oncogene · doi:10.1038/s41388-018-0670-9 · Cited by 57
Zhao, L., Yang, Y., Zhou, P., Ma, H., Zhao, X., He, X., Wang, T., Zhang, J., Liu, Y., & Zhang, T. (2015) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000086 · Cited by 56
Self-citationCD4-CD8 lineage commitment: an inside view
Kappes, D. J., He, X., & He, X. C. (2005) · Nature Immunology · doi:10.1038/ni1230 · Cited by 55
Moskalev, E. A., Luckert, K., Vorobjev, I. A., Mastitsky, S., Gladkikh, A., Stephan, A., Schrenk, M., Kaplanov, K. D., Kalashnikova, O. B., Poetz, O., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-213 · Cited by 55
Shi, X., Zhang, X., Li, J., Mo, L., Zhao, H., Zhu, Y., Hu, Z., Gao, J., & Tan, W. (2017) · International Journal of Cancer · doi:10.1002/ijc.31219 · Cited by 55
Capturing the mammalian Hippo: Elucidating its role in cancer
Nishio, M., Otsubo, K., Maehama, T., Mimori, K., & Suzuki, A. (2013) · Cancer Science · doi:10.1111/cas.12227 · Cited by 54
Carbone, D. P., Morgensztern, D., Moulec, S. L., Santana-Dávila, R., Ready, N., Hann, C. L., Glisson, B. S., Dowlati, A., Rudin, C. M., Lally, S., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.8507 · Cited by 54
Chien, A. J., Haydu, L. E., Biechele, T. L., Kulikauskas, R. M., Rizos, H., Kefford, R. F., Scolyer, R. A., Moon, R. T., & Long, G. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094748 · Cited by 50
β-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL
Kaveri, D., Kastner, P., Dembélé, D., Nerlov, C., Chan, S. H., & Kirstetter, P. (2013) · Blood · doi:10.1182/blood-2012-12-471904 · Cited by 49
Schoumacher, M., Hurov, K. E., Lehár, J., Yan‐Neale, Y., Mishina, Y. M., Sonkin, D., Korn, J. M., Flemming, D., Jones, M. D., Antonakos, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0138-t · Cited by 47
Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth
Huang, J., Hu, W., Hu, L., Previs, R. A., Dalton, H. J., Yang, X.-Y., Sun, Y., McGuire, M. H., Rupaimoole, R., Nagaraja, A. S., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0144 · Cited by 47
Tsubamoto, H., Sonoda, T., Ikuta, S., Tani, S., Inoue, K., & Yamanaka, N. (2015) · PubMed · Cited by 46
Zweidler-McKay, P. A., DeAngelo, D. J., Douer, D., Dombret, H., Ottmann, O. G., Vey, N., Thomas, D. A., Zhu, L., Huang, F., Bajaj, G., et al. (2014) · Blood · doi:10.1182/blood.v124.21.968.968 · Cited by 46
Medulloblastoma in the Molecular Era
Kuzan-Fischer, C. M., Juraschka, K., & Taylor, M. D. (2018) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2018.0028 · Cited by 45
Pine, S. R. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1635 · Cited by 45
McWilliams, R. R., Ko, A. H., Chiorean, E. G., Kwak, E. L., Lenz, H., Nadler, P. I., Wood, D. L., Fujimori, M., Morita, K., Inada, T., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.15_suppl.e15270 · Cited by 44
Lamar, J. M., Nehru, V. M., & Weinberg, G. L. (2018) · Cancers · doi:10.3390/cancers10070229 · Cited by 44
Zou, W., Huang, Z. L., Jiang, T., Shen, Y., Zhao, A., Zhou, S., & Zhang, S. (2017) · Medical Science Monitor · doi:10.12659/msm.907891 · Cited by 42
Catenacci, D. V. T., Bahary, N., Nattam, S. R., Marsh, R., Wallace, J. A., Rajdev, L. N., Cohen, D. J., Sleckman, B. G., Lenz, H., Stiff, P. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.4012 · Cited by 39
Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment
Buglioni, S., Vici, P., Sergi, D., Pizzuti, L., Lauro, L. D., Antoniani, B., Sperati, F., Terrenato, I., Carosi, M., Gamucci, T., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1160187 · Cited by 38
Hedgehog Signaling in Hematopoiesis
Lim, Y., & Matsui, W. H. (2010) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i2.30 · Cited by 37
Casulo, C., Ruan, J., Dang, N. H., Gore, L., Diefenbach, C., Beaven, A. W., Castro, J. E., Porcu, P., Faoro, L., Dupont, J., et al. (2016) · Blood · doi:10.1182/blood.v128.22.5108.5108 · Cited by 35
YAP and WWTR1: New targets for skin cancer treatment
Andl, T., Zhou, L., YANG, K. Y., Kadekaro, A. L., & Zhang, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.001 · Cited by 35
Petrirena, G. J., Masliah‐Planchon, J., Sala, Q., Pourroy, B., Frappaz, D., Tabouret, É., Graillon, T., Gentet, J., Delattre, O., Chinot, O. L., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23699 · Cited by 35
Jinushi, M. (2014) · OncoImmunology · doi:10.4161/onci.28862 · Cited by 34
Tsubamoto, H., Sonoda, T., & Inoue, K. (2014) · PubMed · Cited by 32
Cortes, J. E., Faderl, S. H., Pagel, J. M., Jung, C. W., Yoon, S., Koh, Y., Pardanani, A. D., Hauptschein, R. S., Lee, K.-J., & Lee, J. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.15_suppl.7044 · Cited by 32
A New Strategy Using ALDHhigh-CD8+T Cells to Inhibit Tumorigenesis
Luo, H., Zeng, C., Fang, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103193 · Cited by 30
Jankú, F., Connolly, R. M., LoRusso, P. M., de Jonge, M., Vaishampayan, U. N., Rodon, J. A., Argilés, G., Myers, A. P., Schmitz, S. H., Ji, Y., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-15-c45 · Cited by 27
Iglesias, V. S., Theys, J., Groot, A. J., Barbeau, L. M. O., Lemmens, A., Yaromina, A., Losen, M. H., Houben, R. M. A., Dubois, L. J., & Vooijs, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00460 · Cited by 27
Ueda, T., Tsubamoto, H., Inoue, K., Sakata, K., Shibahara, H., & SONODA, T. (2017) · Anticancer Research · doi:10.21873/anticanres.11720 · Cited by 26
Gracián, A. C., Dean, A. P., Muñoz, A., Hidalgo, M. M., Pazo-Cid, R., Martín-Richard, M., Macarulla, T. M., Lipton, L. R., Harris, M., Manzano-Mozo, J. L., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx369.004 · Cited by 24
Ueda, M., Iguchi, T., Masuda, T., Komatsu, H., Nambara, S., Sakimura, S., Hirata, H., Uchi, R., Eguchi, H., Ito, S., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11562 · Cited by 23
Expression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia
Marsola, A. P. Z. C., Simões, B. P., Palma, L. C., Berzoti-Coelho, M. G., Burin, S. M., & de Castro, F. A. (2018) · Medical Oncology · doi:10.1007/s12032-018-1079-6 · Cited by 23
Vaccines Targeting Cancer Stem Cells: Are They Within Reach?
Dhodapkar, M. V., & Dhodapkar, K. M. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e318233e730 · Cited by 22
ヘッジホッグ経路阻害剤,サリデギブ(IPI-926)はマウス髄芽腫モデルで寿命を延長する
Michelle, J. L., Beryl, A. H., Elisabeth, H. V., Paritosh, C. K., Seth, D. F., Ditzler, S. H., Pullar, B. J., Keith, R., Kerry, F. W., Tunkey, C., et al. (2012) · Cited by 22
Messersmith, W. A., Cohen, S., Shahda, S., Lenz, H., Weekes, C. D., Dotan, E., Denlinger, C. S., O’Neil, B. H., Kapoun, A. M., Zhang, C., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw371.69 · Cited by 20
Pietanza, M. C., Spira, A. I., Jotte, R. M., Gadgeel, S. M., Mita, A. C., Hart, L. L., Gluck, W. L., Chiang, A. C., Liu, S. V., Kapoun, A. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.15_suppl.7508 · Cited by 19
Inoue, K., Tsubamoto, H., Isono‐Nakata, R., Sakata, K., & Nakagomi, N. (2018) · BMC Cancer · doi:10.1186/s12885-018-4520-5 · Cited by 16
Carbone, D., Morgensztern, D., Moulec, S. L., Santana-Dávila, R., Ready, N., Hann, C. L., Glisson, B. S., Dowlati, A., Rudin, C. M., Lally, S., et al. (2019) · Pneumologie · doi:10.1055/s-0039-1678065 · Cited by 9
Sloan, A. E., Nock, C. J., Supko, J. G., Ye, X., Takebe, N., Rich, J. N., Prados, M., & Grossman, S. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou209.17 · Cited by 7
Self-citationHughes, B. G. M., Dean, A. P., Markman, B., Dreisbach, L. P., Provencio, M., Ciuffreda, L., Dear, R. F.-G., Graze, P. R., Nadal, A., Houghton, B., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-17-a084 · Cited by 3
A phase II study of itraconazole in biochemically recurrent prostate cancer.
Lee, M., Hong, H., Kim, W. K., Friedlander, T. W., Fong, L. H., Lin, A., Small, E. J., Dhawan, M. S., Wei, X. X., Rodvelt, T. J., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.6_suppl.362 · Cited by 3
Cited by
Cancer stem cell–immune cell crosstalk in tumour progression
Bayik, D., & Lathia, J. D. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00366-w · Cited by 561
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
Metabolism of Amino Acids in Cancer
Wei, Z., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603837 · Cited by 429
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Shi, Q., Xue, C., Zeng, Y., Yuan, X., Chu, Q., Jiang, S., Wang, J., Zhang, Y., Zhu, D., & Li, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01828-x · Cited by 401
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Zheng, P., Zhou, C., Lu, L., Liu, B., & Ding, Y. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02485-0 · Cited by 352
Metadata
- Authors
- Clara, J. A., Monge, C., Yang, Y., & Takebe, N.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2019-12-02
- Volume
- 17
- Issue
- 4
- Pages
- 204-232
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2991163352
- Cited by
- 752
- References
- 257
- FWCI
- 9.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.